Iron Deficiency Anemia Treatment
Conditions
Keywords
Iron deficiency anemia, Lactoferrin, Ferrous sulfate
Brief summary
Lactoferrin (Lf) is a mammalian cationic iron binding glycoprotein belonging to the transferrin family which was discovered 70 years ago, and isolated simultaneously from human and bovine milks in 1960. It is widely distributed in all biological fluids and is also expressed by immune cells, which release it under stimulation by pathogens
Interventions
treatment for 30 days
DRUGFerrous Sulfate
treatment for 30 days
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
2 Years to 15 Years
Healthy volunteers
No
Inclusion criteria
all patients with iron deficiency anemia from 2 to 15 years old \-
Exclusion criteria
* Anemia rather than iron deficiency anemia. * Family history of blood disease. * Patients with thalassemia trait. * Patients with chronic illness.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia. | 30 days | Complete blood count will be done before and after therapy to detect the effect of the therapy on serum hemoglobin(g/d) |
| Comparison of efficacy of lactoferrin versus ferrous sulfate tharapy in treatment of patients with iron deficiency anemia. | 30 days | Total serum iron(ug/d) will be done before and after therapy to detect effect of the therapy on total serum iron level (ug/d) |
Countries
Egypt
Outcome results
None listed